Model
Edge
Oyster Point Pharma Inc.
0001720725
Filing Type
8-K
Filing Date
6/27/2022
Updated
6/28/22, 11:28 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation, Other Events
EX-99.1
Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation, Other Events
GRAPHIC